Neurology

Article	Citations
Reduced Time to Treatment After Implementation of a Standardized Guideline for the Diagnostic Evaluation and Acute Management of Suspected Autoimmune Encephalitis in Hospitalized Adult Patients (P9-8.	321
Teaching NeuroImage: Foramen Magnum Dural Arteriovenous Fistula Presenting With Thoracolumbar Myelopathy	320
Spinal Cord Infarction Associated with Patent Formale Ovale and Venous Thromboembolism: A Case Report (P8-13.005)	198
Standardized Inpatient Telestroke to Improve Access to Stroke Specialists (P12-14.015)	195
Improving Median Overall Survival (OS) of Glioblastoma (GBM) Patients by Optimizing Standard of Care (SOC) Through Multidisciplinary Team Work and Combination Therapies Including Tumor Treating Fields	189
Frailty increases the risk of Alzheimer’s disease in non-demented individuals: a longitudinal cohort study (P6-3.008)	151
Role of the UNC13 Family in Human Diseases: A Literature Review (P9-2.003)	143
Predicting Cognitive Decline Using Baseline Data in Cognitively Unimpaired Older Adults: Results from the A4 Trial (P2-3.018)	140
Rational Design of a Vaccine for Synucleinopathies Using Computationally-Derived Conformational B Cell Epitopes To Selectively Target Pathogenic Alpha-Synuclein Species (P8-3.007)	136
Traumatic Brain Injury and Depressive Symptoms in Community Dwelling Older Adults (P3-4.007)	131
Lifestyle Contributors to Frequent Headaches in Youth	122
Exploring Clinical Outcomes of ABCDEF Bundle Implementation in Neurocritical Patients: Insights from Two Years of ICU Humanization (P9-7.006)	110
Analysis of the Efficacy of Efgartigimod in a Refractory OMG Patient (P1-11.019)	107
Frequency and Severity of Neurological Symptoms Following Gluten Exposure in Individuals with Celiac Disease (P1-2.010)	107
Impact of Psychiatric Conditions on the Real-world Effectiveness of Eptinezumab Treatment in Patients with Chronic Migraine (P4-12.005)	106
Peripheral Neuropathy	103
Development and Validation of a Nomogram Prediction Model for New Stroke in Community Population (P10-13.004)	102
Teaching Video NeuroImage: Pattern-Induced Seizures Without Photosensitivity in Glutaric Aciduria	102
Resting-state Regional Cerebral Blood Flow Alterations in Macrovasculature and Microvasculature in Parkinson’s Disease: A Systematic Review and Meta-analysis (P3-5.013)	101
Exploring Racial Disparities in Advanced Care Planning Documentation for Stroke Patients (P10-13.020)	100
Rethinking Thunderclap Headaches: A Critical Look at Cerebral Venous Sinus Thrombosis (P3-13.020)	97
Automated Data Extraction Using Large Language Models in Vascular and Interventional Neurology Research: Towards an AI Fully Assistant Automated Research (P9-14.007)	95
Effectiveness of Ataluren in Patients with nmDMD: Confirmatory Evidence from the STRIDE Registry (P7-6.008)	89
Demographic and Regional Trends of Meningitis-related Mortality in the United States from 1999 to 2020: a CDC WONDER Analysis (P3-10.004)	88
Brain Perfusion Imaging and Cardiac Thrombus Detection	88

Capturing Patient and Caregiver Perspectives on Parkinson’s Disease in Zambia: A Methodology (P6-11.014)	87
Patient Education and Unmet Needs: Pregnancy and Postpartum Counseling in MS (P6-1.014)	87
Modifiable Vascular Risk Factors and Subsequent Brain Metrics in Hispanic/Latino Populations	87
IgG4-Related Hypertrophic Pachymeningitis Mimicking Neuromyelitis Optica: a Case Report (P10-8.004)	87
Clinical and Genetic Profiles of Congenital Myasthenic Syndromes: A Single Tertiary Care Center Experience from Saudi Arabia (P12-11.029)	86
Elevated Pre-hospital Blood Pressure is Associated with Reduced Infarct Volume in Large Vessel Occlusion Ischemic Strokes (P12-13.016)	85
Evaluating Brain Health in Women	84
Teaching Video NeuroImage: Reflex Epilepsy—Seizures Triggered by a Geometric Pattern	84
A Novel IONM Protocol for Distal Femoral Extension Osteotomies (P6-6.010)	83
Wobbling Through the Spectrum: Anti-GQ1b Antibody Syndrome Presenting with Generalized Myoclonus and Ataxia (P4-8.018)	81
Case Report of a Unique Structural Cause for Rapidly Progressive Orthostatic Syncope (P7-2.001)	81
Overdiagnosis of Autism Spectrum Disorder: Diagnostic and Management Challenges in a Pediatric Outpatient Clinic (P6-6.003)	80
Outcomes of a Three Week Interdisciplinary Intensive Outpatient Treatment Program for Mild-Moderate Traumatic Brain Injury in Veterans and First Responders (P7-4.006)	80
Having Second Thoughts About Parkinson Diagnosis	79
Hereditary Transthyretin Amyloidosis at Geisinger Medical Center: A Four-year Multidisciplinary Clinic Experience (P6-11.033)	79
Distinguishing Features of MOG Positive and MOG Negative Pediatric Patients with ADEM (S2.008)	79
Consent Deviations in an Acute Ischemic Stroke Clinical Trial (P5-13.017)	76
NETSseq Identifies Novel Therapeutic Targets for Neurodegenerative Diseases (P3-3.008)	76
Effect Sizes of Once-daily Valbenazine for Chorea Associated with Huntington’s Disease: A Post-hoc Analysis of KINECT®-HD Data (P10-5.012)	75
Pediatric SMART Syndrome in a 10-year-old boy: A Case-Report (P5-6.005)	74
Spontaneous Closure Of A Dural Arteriovenous Fistula: A Case Report (P5-14.011)	73
Localizing Lesions in the Peripheral Nervous System using Generative Artificial Intelligence (P1-2.009)	72
The Midbrain Paradox: Bilateral Vertical Gaze Palsy from a Single Sided Lesion (P2-11.007)	72
Severity of Hearing Loss as a Predictor of Dementia Risk: Insights from the ARIC Study (P9-3.013)	72
Multimodal Regression Based Assessment of Longitudinal Evolution Trends in Inflammatory Myositis (IIM) (P3-11.018)	71
Teaching Neuro Images : CNS actinomycosis in an immunocompetent patient	71
Radiological Signs in Spinal Cord Infarct (SCI) and Association with Anatomic Location. (P9-13.005)	71
Inter-Institutional Collaborative Opportunity For Medical Students in the Neurosciences: Annual Student Interest Group in Neurology (SIGN) Forum (P5-5.021)	71
Reader Response: Teaching NeuroImage: Cryptococcal Meningoencephalitis With Cryptococcoma and Gelatinous Pseudocysts	71
My First Patient With Alzheimer's	70
Incidence of Relapses After Meningococcal Vaccination in Clinical Trials of Eculizumab and Ravulizumab in Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)	69
Measles, Rubella, and Varicella-Zoster Viral Antibodies and Clinical Prognosis After 20 Years in Persons with Multiple Sclerosis	69
Comparative Efficacy of Adjuvant Rifampicin, Levofloxacin, and Their Combination in Tuberculous Meningitis With and Without HIV Co-infection: A Systematic Review and Meta-Analysis	68
Assessing the Impact of Immune Checkpoint Inhibitor Therapy on Disease Activity in Multiple Sclerosis Patients	67
Characterization of Clinical Course, Diagnosis, Treatment, and Outcomes of Intravascular Lymphoma with Neurologic Involvement	67
Coexistance of Probable Neurosarcoidosis and Generalized Myasthenia Gravis: Case Report	67
Neuropsychologic Impact of MOGAD: A Patient Reported Outcomes Study	67
Glial Fibrillary Acidic Protein (GFAP) Antibody-Associated Astrocytopathy in Systemic Sarcoidosis	66
Author Response: D313Y Variant in Fabry Disease: A Systematic Review and Meta-analysis	66
NMDA Receptor Encephalitis With Severe Orofacial Dyskinesias Treated With Tramadol and Clonazepam	66
A Broader Perspective on Motor Rehabilitation Guidelines for Cerebral Palsy	65
Racial and Socioeconomic Disparities in Ischemic Stroke Outcomes among Non-lytic/Thrombectomy Patients (P7-5.008)	65
Lysine Reduction and Cognitive Outcomes in Pyridoxine-Dependent Epilepsy	64
Author Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study	63
Autoimmune Cerebellar Ataxia Associated with TNF-Alpha Blocking Therapy in a Patient with Rheumatoid Arthritis: A Case Report and Literature Review (P8-8.003)	63
Performance Assessment of the New EUROLINE Neurologic Syndrome 15 Ag (IgG) for the Determination of Autoantibodies Associated with Neurological Disorders	63
Jugular Variant Bow-Hunter’s Syndrome from Sternocleidomastoid Entrapment of the Internal Jugular Vein (P11-10.001)	63
Group D Salmonella Meningitis in the Neonate (P5-6.010)	62
Nitrous Oxide-Induced Vitamin B12 Deficiency and Myelopathy: A Report of Two Cases (P11-2.006)	62
Dystonia with myoclonus and vertical supranuclear gaze palsy associated with a rare GNB1 variant (P11-11.008)	61

Data-Driven Genome-Wide Association Study of Pain Trajectories in Persons with Parkinson’s Disease (P7-11.012)	61
Improving Residents’ Knowledge and Interest in Outpatient Neurology through an Interactive, Discussion-Based, Patient-Centered Didactic Series (P2-2.006)	61
Neurocognitive Manifestations of Individuals with NF1 Microdeletions (P14-9.007)	61
Assessing Social Cognition Across Dementia Subtypes (P6-6.004)	61
Acute Anterograde Amnesia with Bilateral Hippocampal and Globus Pallidus Lesions (P4-12.007)	61
Serum Glucose Fluctuations Is an Independent Predictor of Adverse Outcomes in Patients with Acute Ischemic Stroke Undergoing Endovascular Treatment (P7-5.014)	59
Analysis of the Epidemiologic Profile, Prevalence, and Incidence of Migraine out of 15,490 Spontaneous Intracranial Hypotension Patients from a Multicenter Record Database (TriNetX) (P2-12.008)	59
Assessing Undergraduate Neurology Pipeline Programs: A Systematic Review (P11-2.001)	58
African-Americans With Multiple Sclerosis Have a Higher Proportion of B-Cell Lineage Cells in Their Cerebrospinal Fluid (CSF) Than White Patients (P9-3.010)	58
Preclinical Development of a T Cell Receptor-engineered Regulatory T Cell Therapy for Progressive MS (S17.004)	58
MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes (P13-5.020)	57
Evaluating Quality of Website-Derived Concussion Information (P8-1.005)	56
Machine-learning Assisted Swallowing Assessment: A Deep Learning-based Quality Improvement Tool to Screen for Post-stroke Dysphagia (S6.004)	56
Survival and Clinical Characteristics of Patients with Glioblastoma with Primitive Neuronal Component (P13-13.004)	56
Identification of a Novel NOTCH3 Mutation in a Case of CADASIL Initially Diagnosed as Demyelinating Disease (P3-3.010)	56
Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment (P6-12.011)	55
Gadolinium Enhancement Patterns in Leptomeningeal Disease (P2-2.001)	55
A Gender Affirming Experience; The RNS System Tracking Seizure Frequency During Gender Changing Hormonal Therapy (P5-9.006)	55
Patterns of Benzodiazepine Initiation Among Older Acute Ischemic Stroke Survivors (P1-10.006)	55
Pathologically- confirmed Osmotic Demyelination in the Case of Clinically and Radiographically Progressive Encephalopathy due to Liver Disease and Malnutrition. (P4-4.007)	55
Levamisole-associated Toxic Multifocal Inflammatory Leukoencephalopathy: A Case Report (P7-3.006)	55
Metronidazole Induced Encephalopathy Responsive to High Dose Thiamine (P4-12.006)	54
Development of eIF2B Activator ABBV-CLS-7262 as a Novel Treatment for Vanishing White Matter Disease (P2-8.001)	54
Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study (P13-5.003)	54
Tenecteplase Is a Better Alternative to Alteplase for Patients With Large Vessel Occlusion Stroke Receiving Bridging Therapy	54
Designing Transgene Vectors for ALS Therapeutics (P11-4.010)	54
COVID-19 Disrupts Sleep Architecture by Reducing N3 Stage Sleep (S25.010)	54
Tuberculous Meningitis: Is the Fixed Dose Anti-TB treatment strategy effective? Case report from Sri Lanka (P3-10.002)	54
Reconsidering the Ethics of Provocation Techniques for Psychogenic Non-epileptic Seizures and Proposed Ethical Guidelines for Use (P2-10.005)	54
Association of Subthalamic Beta Frequency Sub-bands to Symptom Severity in Patients with Parkinson’s Disease: A Systematic Review (P5-11.014)	53
Ixekizumab-associated transverse myelopathy in a patient with psoriatic arthritis (P14-3.017)	53
Recognizing Neuropathic Pain as a Symptom of Charcot-Marie-Tooth Disease that impacts Quality of Life (P14-8.005)	52
Computational Models of Age-associated Cognitive Slowing and Memory Loss (P6-9.010)	52
4 mA tDCS improves walking ability in PSP: A case study (P9-11.012)	52
‘Code Brain’- Mannequin Based Simulation Exercise to Enhance Identification, Evaluation, and Management of Cerebral Herniation for Neurology Residents. (P5-5.027)	52
What’s that Mass? A Sphenoid Lesion Causing Cavernous Sinus Syndrome (P3-14.009)	51
Pearls & Oy-sters: Severe Myotonic Crisis Resembling Malignant Hyperthermia	51
A pioneer in the History of Women in Neurology - Historical Review of the Life and Contributions of Augusta Déjerine-Klumpke (P4-11.009)	51
A Ten-year Delayed Diagnosis of Hereditary Spastic Paraplegia Type-10: Key Clinical, Electrodiagnostic, and Genetic Findings (P11-11.004)	51
Role of 18F-Florzolotau PET in Diagnostic and Therapeutic Decision-Making for Cognitive Impairment (N4.001)	51
Endovascular Therapy for NIHSS ≤5	51
Multimodal Approach to NMOSD Relapse Treatment: Experience with Two Cases (P10-8.011)	51
Role of Pre-operative Mild Cognitive Impairment in Patients Undergoing Deep Brain Stimulation for Parkinson’s Disease: Systematic Review (P2-3.011)	50
The Safety and Efficacy of Chronic Weekly Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis (MG0004) (P4-14.017)	50
The iNPH Radscale May Better Predict Whether Ventriculoperitonal Shunting was Offered, Compared to Drain Trial Gait Variables (P1-5.022)	50
Neuroimaging Evidence of Cortical-subcortical Network Involvement in Patients with Cortical Lateralized Periodic Discharges (P5-1.004)	50
7T MRI Leptomeningeal Enhancement and Brain Atrophy Are Associated with Alterations in Arginine-polyamine Metabolism in Multiple Sclerosis (P11-6.007)	50
Drug-Resistant GAD65-Associated Epilepsy: Pre-Surgical Evaluation and Comparison to Temporal Lobe Epilepsy of Other Etiology (P2-9.005)	50
Serum Neuroinflammatory Biomarkers and Long-term Cognitive Dysfunction (P11-13.002)	50
Personalized Alzheimer’s Risk Reduction Software Improves Calculated Alzheimer’s Risk: A Digital, Decentralized, Randomized Controlled Trial (P1-3.004)	50
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) and Anti-N-Methyl-D-Aspartate Receptor Encephalitis (NMDARE) Overlapping Syndrome Presenting as Tics and Cognitive Symptoms (P10	50
The Path to Finding a Unifying Diagnosis – A Case Report of Mitchell Syndrome in a Pediatric Patient (P2-8.005)	50
Opicapone as First-line Strategy for the Treatment of Wearing-off in Patients with Parkinson’s Disease (P7-5.026)	49
Characteristics of Adult Essential Tremor Patients Seeking Participation in a Decentralized US Clinical Trial: Pre-screener Findings from the Essential3 Program Evaluating Efficacy and Safety of Ulixa	49
Racial Disparities in Mental Health Among Stroke Survivors in the REDUCE Study (P1-13.014)	49
Focal Cerebral CNS Vasculitis due to SARS-CoV-2 Infection (P4-10.007)	49
Perceived Stress and its Association with Sleep Quality in Patients with Neuropathic Pain and Distal Symmetric Polyneuropathy (P3-11.020)	49
Impact of an Inpatient Stroke Education Program on Stroke Knowledge in Lusaka, Zambia (S24.005)	48
Unveiling the Diagnostic and Therapeutic Challenges: A Singular Case of Syphilitic Myelitis in an HIV-Positive Patient (P5-10.007)	48
Blood Pressure Variability as a Marker of Sympathetic Hyperreactivity in Postpartum Patients with Preeclampsia, with and without Chronic Hypertension (P2-7.003)	48
Socioeconomic Disparities in Aspiration Pneumonia Hospitalizations in Parkinson’s Disease Patients (P2-5.006)	48
A Fatal Case of CNS Actinomyces Mimicking Tolosa-Hunt Syndrome: Is it Time to Reevaluate Diagnostic Criteria? (P10-10.004)	48
Pregnancy-related Anticipatory Guidance for People with Epilepsy in Pediatric and Adult Neurology (P1-9.015)	48
Teaching NeuroImage: Wallerian Degeneration of the Corticospinal Tract After Cerebral Hemorrhage	47
Prospective Long-term Seizure Outcomes in Medically-resistant Focal Epilepsy Subjects with Neuromodulation Devices (P3-1.009)	47
Benign Paroxysmal Positional Vertigo: The “SemontPLUS Maneuver” is more effective than the Epley Maneuver – a Prospective Tri-national Randomized Single-Blinded Trial in 195 Patients (S12.003)	46
Collateral Score and Clot Burden Score in the Era of Tenecteplase (P3-13.007)	46
Physiological β-Amyloid Clearance by the Liver and Its Therapeutic Potential for Alzheimer’s Disease (P12-3.010)	46
Cortical Microglial Activation on [F-18]PBR06-PET Predicts Progression Independent of Relapse Activity (PIRA) in Multiple Sclerosis: A 4.5-year Longitudinal Study (S33.006)	46
Cognitive sequelae in MOG antibody-associated disease (P13-5.025)	46
Deep Brain Stimulation (DBS) in Pediatric Dystonia: The Youngest Case of Neuromodulation for Refractory Acquired Dystonia and Status Dystonicus with 1-year Follow-up (P10-5.008)	45
Detecting Smouldering Multiple Sclerosis with Real-world Mobility Monitoring (P2-1.001)	45
PRAX-562 is a Well-Tolerated, Novel Persistent Sodium Channel Blocker with Broad Anticonvulsant Activity in Multiple DEE Mouse Models (S34.007)	45
Expanding the Clinical Spectrum of NUBPL Associated Disorders: Previously Unidentified NUBPL Variants Uncovered by Genome Sequencing in Sibling Pair (P10-6.009)	45
The Grand Masquerade of a Rare Neurological Illness: A Case Report of Anti-IgLON5 Antibody Disease (P3-8.008)	44
Correlation of Headache Frequency and Intensity with the Risk of Obstructive Sleep Apnea in Patients with Idiopathic Intracranial Hypertension (P10-12.007)	44
Contributions of Traumatic Brain Injury and Repetitive Head Impacts to Chronic Deficits in Recognition Memory in Military Veterans (P2-3.020)	44
Neurocognitive Function and Psychiatric Comorbidities in Patients with Epilepsy with Eyelid Myoclonia (P7-9.002)	44
Amelogenesis Imperfecta and Epilepsy	44
Twenty-Year Disparity Trends in U.S. Sleep Disorder Mortality by Age, Race/Ethnicity, Geography, and Socioeconomic Status. (P8-11.020)	43

Brain White Matter Microstructural Alterations in Behcet’s Syndrome Correlate with Cognitive Impairment and Disease Severity: A Diffusion Tensor Imaging Study (P3-1.002)	43
Effgartigimod Helps Avert Post-Thymectomy Crises in Patients with Myasthenia Gravis Classified as MGFA IIIb or Higher (P7-11.026)	43
Diffuse Leptomeningeal Glioneuronal Tumor (DLGNT) with Direct Cystic Infiltration of the Optic Chiasm and Tracts (P1-9.003)	43
Analyzing White Matter Integrity of the Basolateral Amygdala and Subgenual Anterior Cingulate Cortex and Its Association with Depression in Adults with Autism Spectrum Disorder Using the Shannon Entro	42
The Role of Platelet Rich Plasma in the Management of Vertebrogenic and Discogenic Pain (P5-13.004)	42
ICU Management of Severe Myotonic Crisis in the Setting of Beta-Adrenergic Agonist Use: A Case Report (P10-11.012)	42
Mechanical Angioplasty with Comaneci for the Treatment Refractory Vasospasm Secondary to Coccidioidal Meningits (P2-7.005)	42
Measuring Synaptic Density and Dopamine Transporter Availability in Parkinson's Disease: A PET Imaging Study with 11C-UCB-J and 18F-FE-PE2I (P7-3.007)	42
Quantitative Retinal Vascular Features as Biomarkers for CADASIL: A Case-Control Study from the UK Biobank (P9-13.003)	42
Healthcare Resource Utilization in Patients with Stiff-Person Spectrum Disorder (P2-8.003)	42
Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA) (P12-5.028)	42
Teaching NeuroImage: Prognostication of X-Linked Adrenoleukodystrophy Based on the Loes Neuroimaging Score	41
Relationships among Hospital Acute Ischemic Stroke Volumes, Hospital Characteristics, and Outcomes in the US (P14-5.025)	41
Facing the challenges of chief resident year: A standardized experiential simulation leadership curriculum (S13.002)	41
Amyotrophic Lateral Sclerosis Survival and Occupational Lead Exposure in the Danish National Patient Registry (P2-15.002)	41
Risk Factors and Outcome of Cerebrovascular Complications in Transplant Recipients (P14-5.013)	41
Withdrawing Antiseizure Medications in Seizure-Free Patients: The Role of 24-Hour Video EEG (P4-9.013)	41
Examining Age-Specific Barriers and Facilitators to Research Participation in Underrepresented Americans (P14-6.003)	41
Clinical and Autonomic Features Suggest Phenoconversion from Sporadic Adult-onset Ataxia to Clinically Probable Multiple System Atrophy (P6-3.019)	41
Editors' Note: Patient Travel Distance to Neurologist Visits	41
Determining the Impact of Longitudinal Simulation-based Learning and Evaluation on Neurology Trainee Knowledge and Confidence: A Pilot Project (P8-7.005)	40
The Risk of Depression in a Large Huntington Disease Population Compared With Controls: Analysis of the Enroll-HD Registry Data (P1-11.012)	40
Community-driven Brain Health Workshop Series: A Novel Approach to Brain Health Promotion in Rochester’s Historically Marginalized Communities (P1-4.007)	40
A Preliminary Systematic Review and Meta-analysis of Randomized Control Trials of Rimegepant and Zavegepant for Acute Pain Relief from Migraine (P9-12.004)	40
CTA Collaterals, HIR, and Infarct Volume: Which Imaging Modality Best Predicts Clinical Outcomes in Acute Ischemic Stroke Endovascular Treatment? (S2.010)	40
A Novel Variant of NBEA Causing Paroxysmal Kinesogenic Dyskinesia (P8-5.019)	40
Methylation Patterns Differ Between ICH Cases and Controls (S34.002)	40
Unraveling Complexity: Concurrent Myxopapillary Ependymoma and Pancreatic Gastrinoma in a Young Adult - A Syndromic Association or Mere Coincidence? (P6-5.010)	40
Paws for Relief	40
Author Response: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM	39
2024 Annual Highlights of the Resident & Fellow Section: A Representative Collection of Previously Published Articles	39
COVID-19 Infection Presents as Acute Cerebellar Ataxia (P6-10.003)	39
Deep Phenotyping of Executive Function Deficits Using the NIH Toolbox in Duchenne Muscular Dystrophy (P1-11.014)	39
Use of a Trial Innovation Network (TIN) Recruitment Innovation Center (RIC) Survey to Improve Subject Recruitment and Enrollment in an Adolescent Concussion Study: CARE4Kids (P2-14.004)	39
Primary Central Nervous System Histiocytic Sarcoma: A Systematic Review of Clinical Presentation, Radiologic Findings, Treatment Strategies, and Prognostic Outcomes (P9-6.009)	38
Dual antiglutamatergic treatment in patients with status epilepticus: a case series (P9-1.008)	38
Predictive Factors in Serious Non-traumatic Headache: A Caribbean Country Perspective (P3-12.008)	38
Therapeutic Efficacy of Repetitive Nerve Stimulation (RNS) Therapy in Functional Movement Disorders: A Quantitative and Qualitative Analysis (N6.003)	38
Refining Neuro-ophthalmology Examination Proficiency in Neurology Residents Through Simulation-based Training (S14.005)	38
Synergistic effect of MTHFR polymorphisms in arterial ischemic stroke in young adult (P3-5.014)	38
The COVID-19 Pandemic Significantly Affected Acute Ischemic Stroke Subtype, Patient Characteristics, and Outcomes (P8-11.018)	38
Acquired Hepatocerebral Degeneration: The Second Brain (HNS and CNS) (P8-5.029)	38
A Comparison of Subperiosteal or Subgaleal Drainage with Subdural Drainage on The Outcome of Chronic Subdural Hematoma Surgery (P7-11.012)	38
Distance Travelled by patient for appointment with the Movement disorder clinic at Kentucky Neuroscience Institute – how to solve the problem? (P10-11.005)	38
Real-world Outcomes with Directional Deep Brain Stimulation (DBS) Systems: Awake Versus Asleep Lead Placement (P9-5.011)	38
Digital Solutions: Exploring the Impact of Online Cognitive Rehabilitation on Quality of Life in Multiple Sclerosis Patients (P4-1.002)	38
A Unique Presentation of Paraneoplastic-Variant Stiff Person Syndrome (P2-8.020)	38
Brain MRI Activity During the Year Before Pregnancy Can Predict Long-Term Clinical Worsening in Patients with Multiple Sclerosis (P11-3.018)	37
Editors' Note: Association of Polysomnographic Sleep Parameters With Neuroimaging Biomarkers of Cerebrovascular Disease in Older Adults With Sleep Apnea	37
Predicting Outcomes and Prognosis in Adult Myelopathies in Adult Non-traumatic Myelopathies (P11-14.003)	37
Investigating the Impact of Virtual Versus In-Person Small Group Discussion on Academic Performance in a First-Year Medical Neuroscience Course (S10.003)	37
Valproic Acid is an Effective Anti-Emetic Treatment in Alexander Disease (P10-9.010)	37
Impact of Serotonin Reuptake Inhibitors on Respiratory Patterns During Seizures in Adults with Epilepsy Undergoing SEEG Monitoring. (P4-9.004)	37
Chronic Kidney Disease and Risk of Intracerebral Hemorrhage: The Role of Hypertension as a Mediator (S34.004)	37
Association Between a Brain Care Score and Risk of Cerebrovascular Events in American Women (S11.004)	37
COVID-19 Outcomes in Neurosarcoidosis (P9-5.012)	36
Monoaminergic Network Abnormalities Explain Fatigue in Pediatric Multiple Sclerosis (S8.008)	36
Evaluating an Intergenerational Art and Storytelling Program with Older Adults and Medical Students (P5-9.016)	36
Association Between DMD Genotype and Neurodevelopmental Concerns in Childhood-Onset Dystrophinopathy Using Population-Based Surveillance Data (P7-6.005)	36
Temporal Trends in Quality of Acute Stroke and Secondary Stroke Prevention Care in Patients with Pre-stroke Disability in the Safe Implementation of Treatment in Stroke (SITS) Registry (P1-5.002)	36
ChatGPT as Clinical Decision-Making Tool for Headache Screening (P4-12.009)	36
Exposure-Response Modeling to Describe Change in Brain Amyloid Following Lecanemab Administration in Patients with Early Alzheimer’s Disease (P9-9.011)	36
Structural Connectivity Changes in Brain Network After Spinal Cord Injury (P10-4.001)	36
Geographic Distribution of Amyotrophic Lateral Sclerosis (ALS) in the Chicagoland Area (P6-11.015)	36
Patient Use of Smartphone Videos to Capture Events in an Outpatient Epilepsy Practice (P7-1.009)	36
Implementation of Depression Screening and Interventions Protocol in a Pediatric Neurology Residents’ Continuity Clinic: A Quality Improvement Project (P11-9.001)	35
Level of Blood Tau and pTau : A Non-Invasive Approach for the Diagnosis of Alzheimer’s Disease(AD). (P7-3.018)	35
Sex Chromosomes and Gonad-dependent Sex Differences in Auditory Function in Mice (P7-10.001)	35
Acute Spinal Cord Infarction Following Cannabis Exposure (P7-5.015)	35
Bariatric Surgery as a Potential Trigger for Worsening HSP (P2-11.020)	35
Cervical Motion Alterations and Brain Functional Connectivity in Cervical Dystonia (P1-3.014)	35
Association of Disease Characteristics with Utilization of Behavioral Medicine in Patients with NMOSD and MOGAD (P13-5.016)	35
The Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease: A Single Center Experience (P9-14.018)	35
Anti-NMDA Encephalitis Co-positive with Aquaporin 4 Antibodies in a 4-year-old Female (P6-8.004)	35
Predictors of Post-Discharge Seizures in Aneurysmal Subarachnoid Hemorrhage Using EEG Data (S30.007)	35
Burkitt Lymphoma-associated GAD65 Encephalitis in a Child with New-onset, Refractory Seizures (P1-14.007)	35
Reduced Aβ Amyloid Deposits Relate to Inflammation and Neuronal Survival in Multiple Sclerosis Cortex (S17.003)	35
Aqueously diffusible RNA-bound amyloid-β aggregates in Alzheimer disease brain (P1-6.004)	35
Spontaneous Spinal Epidural Hematoma Presented with Acute Hemiparesis: A Stroke Mimicker (P11-5.015)	35
Three Month Functional Outcomes in Poor Grade Subarachnoid Hemorrhage Patients Undergoing Endovascular Treatment of Cerebral Vasospasm (P7-5.032)	35
Pathogenic MUYTH and Novel H3F3A Variants in Glioblastoma: A Case Report and Literature Review (P4-5.005)	35
Proximity to Green and Blue Spaces and Serious Psychological Distress in Urban-Dwelling Older Adults: Analysis of Washington State BRFSS data (P2-12.006)	35
Clonidine Withdrawal Resulting in Atypical Presentation of PRES (P2-8.007)	34
Comparison of Symptom Distribution and Severity in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Zambia (P9-1.013)	34
Evaluation of the Clinical Outcomes and Disease Burden in Advanced Parkinson’s Disease Patients: PROSPECT Study Preliminary Results (P10-11.009)	34
The initial reduction in the percentage of peripheral lymphocytes and long disease course are associated with sustained response to Dimethyl Fumarate (DMF) in a small cohort of patients with Relapsing	34
Investigation of Novel Variants in Familial Multiple Sclerosis Through Family-based Association Tests and Segregation Analyses (S17.007)	34
Assessing Clinically Relevant Recovery of Visual Acuity Over Time in Patients with Leber Hereditary Optic Neuropathy Treated with Idebenone: Results from the LEROS Study (S40.001)	34
The relationship between gender, peer victimization, mental health, and frequent headaches in adolescents: A Canadian population-based observational study (P14-12.002)	34
The Quix Test: Identifying Vestibular Dysfunction in the “Dizzy Patient” (P7-4.004)	34
Message From the Editors to Our Reviewers	34
Efficacy of Adjunctive Cenobamate by Focal Seizure Subtypes: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study in a Multinational Asian Population (P8-9.006)	34
Airborne Trichloroethylene Exposure and Parkinson’s Disease Risk in Medicare Beneficiaries (S2.001)	34
Prevalence of Autoantibody Positivity and Associated Neuropathologies in the Oldest-old (P3-6.009)	34
Implementing and Assessing a Neuropalliative Communication Curriculum for Neurology Resident Physicians (P6-7.003)	33